Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Roxadustat Versus Darbepoetin Alfa on Iron Repletion Effects in the Management of Anemia in Hemodialysis Patients

NCT07517744 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07517744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07517744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Roxadustat Versus Darbepoetin Alfa on Iron Repletion Effects in the Management of Anemia in Hemodialysis Patients
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
June 12, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd anemia, ckd anemia in stable dialysis patients